Repression of rRNA gene transcription by endothelial SPEN deficiency normalizes tumor vasculature via nucleolar stress
Journal of Clinical Investigation · 16.10.2023 · 133 (20)
DOI: 10.1172/jci159860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.10.2023. Verfasst von Zi-Yan Yang und 14 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation, the Key Research and Development Program of Shaanxi Province.
Abstract (Originalsprache)
Human cancers induce a chaotic, dysfunctional vasculature that promotes tumor growth and blunts most current therapies; however, the mechanisms underlying the induction of a dysfunctional vasculature have been unclear. Here, we show that split end (SPEN), a transcription repressor, coordinates rRNA synthesis in endothelial cells (ECs) and is required for physiological and tumor angiogenesis. SPEN deficiency attenuated EC proliferation and blunted retinal angiogenesis, which was attributed to p53 activation. Furthermore, SPEN knockdown activated p53 by upregulating noncoding promoter RNA (pRNA), which represses rRNA transcription and triggers p53-mediated nucleolar stress. In human cancer biopsies, a low endothelial SPEN level correlated with extended overall survival. In mice, endothelial SPEN deficiency compromised rRNA expression and repressed tumor growth and metastasis by normalizing tumor vessels, and this was abrogated by p53 haploinsufficiency. rRNA gene transcription is driven by RNA polymerase I (RNPI). We found that CX-5461, an RNPI inhibitor, recapitulated the effect of Spen ablation on tumor vessel normalization and combining CX-5461 with cisplatin substantially improved the efficacy of treating tumors in mice. Together, these results demonstrate that SPEN is required for angiogenesis by repressing pRNA to enable rRNA gene transcription and ribosomal biogenesis and that RNPI represents a target for tumor vessel normalization therapy of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- the National Natural Science Foundation
- the Key Research and Development Program of Shaanxi Province
Zitieren
APA
Yang, Z. Y., Yan, X. C., Zhang, J. Y., Liang, L., Gao, C. C., Zhang, P. R., Liu, Y., Sun, J. X., Ruan, B., Duan, J. L., Wang, R. N., Feng, X. X., Che, B., Xiao, T., & Han, H. (2023). Repression of rRNA gene transcription by endothelial SPEN deficiency normalizes tumor vasculature via nucleolar stress. Journal of Clinical Investigation, 133(20). https://doi.org/10.1172/jci159860
Vancouver
Yang ZY, Yan XC, Zhang JY, Liang L, Gao CC, Zhang PR, et al. Repression of rRNA gene transcription by endothelial SPEN deficiency normalizes tumor vasculature via nucleolar stress. Journal of Clinical Investigation. 2023;133(20). doi:10.1172/jci159860
BibTeX
@article{Yang2023,
author = {Yang, Zi-Yan and Yan, Xian-Chun and Zhang, Jia-Yu-Lin and Liang, Liang and Gao, Chun-Chen and Zhang, Pei-Ran and Liu, Yuan and Sun, Jia-Xing and Ruan, Bai and Duan, Juan-Li and Wang, Ruo-Nan and Feng, Xing-Xing and Che, Bo and Xiao, Tian and Han, Hua},
title = {Repression of rRNA gene transcription by endothelial SPEN deficiency normalizes tumor vasculature via nucleolar stress},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {20},
doi = {10.1172/jci159860}
}
EUVIMED